Tag: Tecfidera
Tecfidera (dimethyl fumarate) and Tysabri (natalizumab) data demonstrate improved outcomes with...
Biogen has announced new real-world data that show treatment with its multiple sclerosis (MS) therapies, Tecfidera (dimethyl fumarate) and Tysabri (natalizumab), early in the...
Tecfidera (dimethyl fumarate) real-world studies affirm sustained efficacy and demonstrate nine-year...
Biogen has announced new Tecfidera (dimethyl fumarate) data at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)...
